Skip to main content

Table 2 Ovulation results and MI plasma concentration in patients undergoing the first and the second phase of the study

From: Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women

 

MI plasma levels

Ovulation

 

T0 μmol/l

T3 μmol/l

T3 (n)

First phase:

treatment with MI alone for 3 months in all patients (no. = 37)

38 ± 2.9

23/37

Second phase:

treatment with MI + α-LA for 3 (further) months in MI-resistant women (no. = 14)

17 ± 3.5a

35 ± 3.8b

12/14

  1. Values are expressed as mean ± SD. T0 baseline; T3 end of treatment (three months)
  2. athis value was found in MI-resistant subjects in the first phase after MI treatment (T3) and represents the baseline value of the second phase
  3. bMI plasma levels in MI-resistant women at T3 were found to be significantly (p <  0.001) higher than at T0